Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308489930> ?p ?o ?g. }
- W4308489930 endingPage "923" @default.
- W4308489930 startingPage "911" @default.
- W4308489930 abstract "Designed antimicrobial lipopeptides (ALPs) offer the attractive benefits of short peptide sequences and flexible tuning of amphiphilicity by altering the acyl chain length. These lipopeptides kill microbes by forming intriguing in-membrane nanostructures and causing the leakage of internal contents. However, how subtle differences in the molecular structures of the lipopeptides affect their antimicrobial efficacy and biocompatibility to host cells is still under-investigated. This work focuses on assessing changes in the acyl chain length of CH3(CH2)n-2CO-KKKIII-NH2 (n = 10, 12 and 14, K = lysine, I = isoleucine, denoted as CnKI3) on the antimicrobial potency and cytotoxicity by combining biological assays with physical measurements. Aggregation properties were characterized by changes in critical aggregation concentration (CAC) from surface tension measurements. Antimicrobial susceptibility tests, cytotoxic MTT assays, haemolytic tests, and dynamic bactericidal experiments were employed to reveal their bioactive potency toward different types of cells. To further investigate lipopeptides’ underlying antimicrobial and cytotoxic mechanisms, lipid monolayer and lipid small unilamellar vesicle (SUV) models were established and biophysically characterized. An increase in n led to the decrease in the CAC of CnKI3, showing a rising membrane-lytic power. Subsequent bioactive measurements revealed the optimal performance of C12KI3 from this series of lipopeptides. The selective membrane binding behaviour was well supported by neutron reflection data from charged lipid monolayer models, revealing membrane-supported nanostructures of ALPs. However, increased membrane-lytic actions in C14KI3 led to notably increased toxicity and reduced selectivity. On the other hand, C14KI3 can impose faster dynamic killing than natural lipopeptide polymyxin B, showing the distinct impact of the amphiphilic balance from the designed lipopeptide. In contrast, the distinctly weaker binding to zwitterionic membrane models (monolayers and SUVs) provided direct nanoscale structural evidence to the mildness of the designed ALPs on host cells. This work demonstrates the high selectivity and fast killing of rationally designed short ALPs to microbes via in-membrane nanostructuring." @default.
- W4308489930 created "2022-11-12" @default.
- W4308489930 creator A5015666517 @default.
- W4308489930 creator A5030131037 @default.
- W4308489930 creator A5052016306 @default.
- W4308489930 creator A5073059937 @default.
- W4308489930 creator A5076106823 @default.
- W4308489930 creator A5076231676 @default.
- W4308489930 date "2023-01-01" @default.
- W4308489930 modified "2023-10-18" @default.
- W4308489930 title "Acyl chain length tuning improves antimicrobial potency and biocompatibility of short designed lipopeptides" @default.
- W4308489930 cites W1926854487 @default.
- W4308489930 cites W1963570064 @default.
- W4308489930 cites W1963998426 @default.
- W4308489930 cites W1971756895 @default.
- W4308489930 cites W1973780741 @default.
- W4308489930 cites W1978046661 @default.
- W4308489930 cites W1979973356 @default.
- W4308489930 cites W1980616767 @default.
- W4308489930 cites W1982099296 @default.
- W4308489930 cites W1982532030 @default.
- W4308489930 cites W1990394752 @default.
- W4308489930 cites W1992253030 @default.
- W4308489930 cites W1995151636 @default.
- W4308489930 cites W2001123674 @default.
- W4308489930 cites W2004022464 @default.
- W4308489930 cites W2010666335 @default.
- W4308489930 cites W2013588942 @default.
- W4308489930 cites W2015442088 @default.
- W4308489930 cites W2024650759 @default.
- W4308489930 cites W2024956916 @default.
- W4308489930 cites W2027150571 @default.
- W4308489930 cites W2032589739 @default.
- W4308489930 cites W2036860085 @default.
- W4308489930 cites W2051750619 @default.
- W4308489930 cites W2052753851 @default.
- W4308489930 cites W2063620226 @default.
- W4308489930 cites W2067299341 @default.
- W4308489930 cites W2068334584 @default.
- W4308489930 cites W2071581047 @default.
- W4308489930 cites W2083183071 @default.
- W4308489930 cites W2089137287 @default.
- W4308489930 cites W2098151972 @default.
- W4308489930 cites W2107050135 @default.
- W4308489930 cites W2110320743 @default.
- W4308489930 cites W2128912763 @default.
- W4308489930 cites W2130444227 @default.
- W4308489930 cites W2133056039 @default.
- W4308489930 cites W2135465392 @default.
- W4308489930 cites W2139881450 @default.
- W4308489930 cites W2149583102 @default.
- W4308489930 cites W2151967603 @default.
- W4308489930 cites W2159861471 @default.
- W4308489930 cites W2164271129 @default.
- W4308489930 cites W2180752973 @default.
- W4308489930 cites W2205541320 @default.
- W4308489930 cites W2231020609 @default.
- W4308489930 cites W2292255428 @default.
- W4308489930 cites W2303771534 @default.
- W4308489930 cites W2523230607 @default.
- W4308489930 cites W2560254277 @default.
- W4308489930 cites W2624416245 @default.
- W4308489930 cites W2748403405 @default.
- W4308489930 cites W2765097535 @default.
- W4308489930 cites W2846854323 @default.
- W4308489930 cites W2899121039 @default.
- W4308489930 cites W2992209383 @default.
- W4308489930 cites W3017122404 @default.
- W4308489930 cites W3083872481 @default.
- W4308489930 cites W3110599137 @default.
- W4308489930 cites W4210968711 @default.
- W4308489930 cites W4241099669 @default.
- W4308489930 cites W4280514775 @default.
- W4308489930 doi "https://doi.org/10.1016/j.jcis.2022.10.114" @default.
- W4308489930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36368131" @default.
- W4308489930 hasPublicationYear "2023" @default.
- W4308489930 type Work @default.
- W4308489930 citedByCount "2" @default.
- W4308489930 countsByYear W43084899302023 @default.
- W4308489930 crossrefType "journal-article" @default.
- W4308489930 hasAuthorship W4308489930A5015666517 @default.
- W4308489930 hasAuthorship W4308489930A5030131037 @default.
- W4308489930 hasAuthorship W4308489930A5052016306 @default.
- W4308489930 hasAuthorship W4308489930A5073059937 @default.
- W4308489930 hasAuthorship W4308489930A5076106823 @default.
- W4308489930 hasAuthorship W4308489930A5076231676 @default.
- W4308489930 hasBestOaLocation W43084899301 @default.
- W4308489930 hasConcept C109316439 @default.
- W4308489930 hasConcept C12554922 @default.
- W4308489930 hasConcept C159047783 @default.
- W4308489930 hasConcept C178790620 @default.
- W4308489930 hasConcept C182615771 @default.
- W4308489930 hasConcept C185154212 @default.
- W4308489930 hasConcept C185592680 @default.
- W4308489930 hasConcept C201399114 @default.
- W4308489930 hasConcept C202751555 @default.
- W4308489930 hasConcept C2522874641 @default.
- W4308489930 hasConcept C2776102837 @default.